Back to Search Start Over

Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer.

Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer.

Authors :
Kim, Yongbok
Parda, David S.
Trombetta, Mark G.
Colonias, Athanasios
Werts, E. Day
Miller, Linda
Miften, Moyed
Source :
Medical Physics; Dec2007, Vol. 34 Issue 12, p4640-4648, 9p, 2 Color Photographs, 1 Chart, 4 Graphs
Publication Year :
2007

Abstract

A dosimetric comparison was performed on external-beam three-dimensional conformal partial breast irradiation (PBI) and whole breast irradiation (WBI) plans for patients enrolled in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-39/Radiation Therapy Oncology Group (RTOG) 0413 protocol at our institution. Twenty-four consecutive patients were treated with either PBI (12 patients) or WBI (12 patients). In the PBI arm, the lumpectomy cavity was treated to a total dose of 38.5 Gy at 3.85 Gy per fraction twice daily using a four-field noncoplanar beam setup. A minimum 6 h interval was required between fractions. In the WBI arm, the whole breast including the entirety of the lumpectomy cavity was treated to a total dose of 50.4 Gy at 1.8 Gy per fraction daily using opposed tangential beams. The lumpectomy cavity volume, planning target volume for evaluation (PTV_EVAL), and critical structure volumes were contoured for both the PBI and WBI patients. Dosimetric parameters, dose volume histograms (DVHs), and generalized equivalent uniform dose (gEUD) for target and critical structures were compared. Dosimetric results show the PBI plans, compared to the WBI plans, have smaller hot spots in the PTV_EVAL (maximum dose: 104.2% versus 110.9%) and reduced dose to the ipsilateral breast (V50: 48.6% versus 92.1% and V100: 10.2% versus 50.5%), contralateral breast (V3: 0.16% versus 2.04%), ipsilateral lung (V30: 5.8% versus 12.7%), and thyroid (maximum dose: 0.5% versus 2.0%) with p values ≤0.01. However, similar dose coverage of the PTV_EVAL (98% for PBI and 99% for WBI, on average) was observed and the dose difference for other critical structures was clinically insignificant in both arms. The gEUD data analysis showed the reduction of dose to the ipsilateral breast and lung, contralateral breast and thyroid. In addition, preliminary dermatologic adverse event assessment data suggested reduced skin toxicity for patients treated with the PBI technique. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00942405
Volume :
34
Issue :
12
Database :
Complementary Index
Journal :
Medical Physics
Publication Type :
Academic Journal
Accession number :
27758794
Full Text :
https://doi.org/10.1118/1.2799579